Related Experiment Video

Updated: Aug 18, 2026

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Growth factor regulation of a 26S proteasomal subunit in breast cancer

Christopher J Barnes1, Feng Li, Amjad H Talukder

  • 1Department of Molecular and Cellular Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|April 20, 2005
PubMed
Abstract

Insights

Heregulin-beta1 (HRG) upregulates the S4 proteasome subunit in breast cancer cells, an effect blocked by herceptin. This suggests proteasome inhibitors may benefit HRG-driven breast cancers.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cellular mechanisms

Background:

  • Heregulin-beta1 (HRG) is a growth factor implicated in breast cancer progression.
  • Understanding HRG's molecular targets is crucial for developing targeted therapies.
  • The 26S proteasome plays a role in protein degradation and cellular regulation.

Purpose of the Study:

  • To identify proteins regulated by heregulin-beta1 (HRG) in breast epithelial cells.
  • To characterize the role of HRG in modulating protein expression, localization, and function.
  • To investigate the impact of the therapeutic antibody herceptin on HRG-regulated proteins.

Main Methods:

  • Differential display mRNA screening to identify HRG-regulated genes.
  • Biochemical and functional assays to study protein expression and activity.
  • Analysis of protein localization using immunofluorescence and coimmunoprecipitation.

Main Results:

  • Identified the ATPase subunit 4 (S4) of the 26S proteasome as an HRG-regulated target.
  • HRG increased S4 mRNA and protein levels, an effect inhibited by herceptin.
  • S4 expression was elevated in human breast tumors, particularly estrogen receptor-negative types.
  • HRG stimulation led to increased S4 activity and functional proteasome complex formation.

Conclusions:

  • This study demonstrates growth factor-regulated expression, localization, and activity of the S4 proteasome subunit in breast cancer.
  • Findings provide a mechanistic basis for using proteasome inhibitors in HRG-driven breast cancers.
  • Highlights the interplay between HRG signaling and proteasome function in cancer biology.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...